Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remdesivir vs Remdesivir + Lopinavir/Ritonavir in COVID-19
NCT04738045Phase 4Unknown
- Start
- Nov 2020
- Primary completion
- Mar 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of lopinavir and ritonavir in coronavirus disease 2019 (COVID-19) (2 arms). Primary endpoint: Proportion of cured patients at 3 months. Status: unknown.
02
Drugs
lopinavirritonavir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04738045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04738045.